Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

TARO Taro Pharmaceutical Industries Ltd

42,97

0,00 (0,00%)

Zuletzt aktualisiert: 01:00:00

Verzögert um 15 Minuten

Taro to Release Third Quarter Results on January 25, 2024

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended December 31, 2023, after the close of market on Thursday, January 25, 2024.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240119038585/en/

William J. Coote VP, Chief Financial Officer (914) 345-9001 William.Coote@taro.com

Taro Pharmaceutical Indu... (NYSE:TARO)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Taro Pharmaceutical Indu... Charts.

Taro Pharmaceutical Indu... (NYSE:TARO)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Taro Pharmaceutical Indu... Charts.

News Taro Pharmaceutical Industries Ltd

Taro Shareholders Approve Merger with Sun Pharma
Donnerstag 23 Mai 2024 (7 Monate vor) • PR Newswire (US)

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
Donnerstag 23 Mai 2024 (7 Monate vor) • Edgar (US Regulatory)

Taro Shareholders Approve Merger with Sun Pharma
Donnerstag 23 Mai 2024 (7 Monate vor) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 23 Mai 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 21 Mai 2024 (7 Monate vor) • Edgar (US Regulatory)

Taro Provides Results for Year Ended March 31, 2024
Montag 20 Mai 2024 (7 Monate vor) • Business Wire

Taro to Release Full Year Results on May 20, 2024
Mittwoch 15 Mai 2024 (7 Monate vor) • Business Wire

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
Dienstag 14 Mai 2024 (7 Monate vor) • Edgar (US Regulatory)

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
Mittwoch 8 Mai 2024 (8 Monate vor) • Edgar (US Regulatory)

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger
Mittwoch 8 Mai 2024 (8 Monate vor) • Business Wire

Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Montag 15 April 2024 (8 Monate vor) • Business Wire

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
Montag 11 März 2024 (10 Monate vor) • Edgar (US Regulatory)

Weitere Taro Pharmaceutical Industries Ltd News-Artikel

Saratoga Investment

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen